Richard Whyte

Richard Whyte, MD, MBA

Vice Chair of Quality Safety and Clinical Affairs, Beth Israel Deaconess Medical Center
Professor of Surgery, Harvard Medical School

Richard Whyte, MD, MBA, is the vice chair of surgery at Beth Israel Deaconess Medical Center and a professor of surgery at Harvard Medical School. Richard received his BS in chemistry, his MD from the University of Pittsburgh, and MBA from the Wharton School at the University of Pennsylvania. He is interested in bioethical issues pertaining to the field of surgery—particularly cardiothoracic surgery. Richard is on the ethics committees of two national surgical organizations, the Society of Thoracic Surgeons (chair) and the American College of Surgeons.

Publications View
Hepatitis C virus-infected resident: end of residency, end of career?
Authors: Authors: Dresler CM, Kent MS, Whyte RI, Sade RM.
Ann Thorac Surg
View full abstract on Pubmed
A pilot cohort study of the determinants of longitudinal opioid use after surgery.
Authors: Authors: Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC.
Anesth Analg
View full abstract on Pubmed
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
Authors: Authors: Merritt RE, Whyte RI, D'Arcy NT, Hoang CD, Shrager JB.
Ann Thorac Surg
View full abstract on Pubmed
Benign emptying of the postpneumonectomy space.
Authors: Authors: Merritt RE, Reznik SI, DaSilva MC, Sugarbaker DJ, Whyte RI, Donahue DM, Hoang CD, Smythe WR, Shrager JB.
Ann Thorac Surg
View full abstract on Pubmed
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer.
Authors: Authors: Das M, Donington JS, Murphy J, Kozak M, Eclov N, Whyte RI, Hoang CD, Zhou L, Le QT, Loo BW, Wakelee H.
Clin Lung Cancer
View full abstract on Pubmed
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Authors: Authors: Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, Wakelee HA, Loo BW.
J Thorac Oncol
View full abstract on Pubmed
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
Authors: Authors: Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J.
J Thorac Oncol
View full abstract on Pubmed
Invited commentary.
Authors: Authors: Whyte R.
Ann Thorac Surg
View full abstract on Pubmed
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Authors: Authors: Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ.
Clin Cancer Res
View full abstract on Pubmed
Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Authors: Authors: Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA.
Ann Thorac Surg
View full abstract on Pubmed

Address: 
Beth Israel Deaconess Medical Center
Dept' of Surgery, Ste 9F
110 Francis Street
Boston, MA 02215